|
1
|
Garg AK, Mai WY, McGary JE, Grant WH III,
Butler EB and Teh BS: Radiation proctopathy in the treatment of
prostate cancer. Int J Radiat Oncol Biol Phys. 66:1294–1305. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Elliott SP and Malaeb BS: Long-term
urinary adverse effects of pelvic radiotherapy. World J Urol.
29:35–41. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wedlake LJ, Thomas K, Lalji A, Blake P,
Khoo VS, Tait D and Andreyev HJ: Predicting late effects of pelvic
radiotherapy: is there a better approach? Int J Radiat Oncol Biol
Phys. 78:1163–1170. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zelefsky MJ, Levin EJ, Hunt M, Yamada Y,
Shippy AM, Jackson A and Amols HI: Incidence of late rectal and
urinary toxicities after three-dimensional conformal radiotherapy
and intensity-modulated radiotherapy for localized prostate cancer.
Int J Radiat Oncol Biol Phys. 70:1124–1129. 2008. View Article : Google Scholar
|
|
5
|
Lawton CA, Won M, Pilepich MV, Asbell SO,
Shipley WU, Hanks GE, Cox JD, Perez CA, Sause WT, Doggett SR and
Rubin P: Long-term treatment sequelae following external beam
irradiation for adenocarcinoma of the prostate: analysis of RTOG
studies 7506 and 7706. Int J Radiat Oncol Biol Phys. 21:935–939.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Crew JP, Jephcott CR and Reynard JM:
Radiation-induced haemorrhagic cystitis. Eur Urol. 40:111–123.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
No authors listed. Physical status: the
use and interpretation of anthropometry. Report of a WHO Expert
Committee. World Health Organ Tech Rep Ser. 854:1–452.
1995.PubMed/NCBI
|
|
8
|
Freedland SJ and Platz EA: Obesity and
prostate cancer: making sense out of apparently conflicting data.
Epidemiol Rev. 29:88–97. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hsing AW, Sakoda LC and Chua S Jr:
Obesity, metabolic syndrome and prostate cancer. Am J Clin Nutr.
86:s843–s857. 2007.PubMed/NCBI
|
|
10
|
Thomas JA II and Freedland SJ: Obesity and
prostate cancer: collateral damage in the battle of the bulge.
Front Biosci (Schol Ed). 3:594–605. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zilli T, Nguyen TV, Bahary JP, Chagnon M,
Dufresne A and Taussky D: Prognostic impact of abdominal adiposity,
waist circumference and body mass index in patients with
intermediate-risk prostate cancer treated with radiotherapy. Int J
Obes (Lond). 35:1421–1426. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Efstathiou JA, Chen MH, Renshaw AA,
Loffredo MJ and D’Amico AV: Influence of body mass index on
prostate-specific antigen failure after androgen suppression and
radiation therapy for localized prostate cancer. Cancer.
109:1493–1498. 2007. View Article : Google Scholar
|
|
13
|
Palma D, Pickles T and Tyldesley S;
Prostate Cohort Outcomes Initiative. Obesity as a predictor of
biochemical recurrence and survival after radiation therapy for
prostate cancer. BJU Int. 100:315–319. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Geinitz H, Thamm R, Mueller T, Jess K,
Zimmermann FB, Molls M and Nieder C: Impact of body mass index on
outcomes after conformal radiotherapy in patients with prostate
cancer. Int J Radiat Oncol Biol Phys. 81:16–22. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Efstathiou JA, Skowronski RY, Coen JJ,
Grocela JA, Hirsch AE and Zietman AL: Body mass index and
prostate-specific antigen failure following brachytherapy for
localized prostate cancer. Int J Radiat Oncol Biol Phys.
71:1302–1308. 2008. View Article : Google Scholar
|
|
16
|
D’Amico AV, Whittington R, Malkowicz SB,
Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA,
Kaplan I, Beard CJ and Wein A: Biochemical outcome after radical
prostatectomy, external beam radiation therapy, or interstitial
radiation therapy for clinically localized prostate cancer. JAMA.
280:969–974. 1998.
|
|
17
|
Vargas C, Martinez A, Kestin LL, Yan D,
Grills I, Brabbins DS, Lockman DM, Liang J, Gustafson GS, Chen PY,
Vicini FA and Wong JW: Dose-volume analysis of predictors for
chronic rectal toxicity after treatment of prostate cancer with
adaptive image-guided radiotherapy. Int J Radiat Oncol Biol Phys.
62:1297–1308. 2005.
|
|
18
|
Yoshizumi T, Nakamura T, Yamane M, Islam
AH, Menju M, Yamasaki K, Arai T, Kotani K, Funahashi T, Yamashita S
and Matsuzawa Y: Abdominal fat: standardized technique for
measurement at CT. Radiology. 211:283–286. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Trotti A, Colevas AD, Setser A, et al:
CTCAE v3.0: development of a comprehensive grading system for the
adverse effects of cancer treatment. Semin Radiat Oncol.
13:176–181. 2003. View Article : Google Scholar
|
|
20
|
Peeters ST, Heemsbergen WD, van Putten WL,
Slot A, Tabak H, Mens JW, Lebesque JV and Koper PC: Acute and late
complications after radiotherapy for prostate cancer: results of a
multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat
Oncol Biol Phys. 61:1019–1034. 2005. View Article : Google Scholar
|
|
21
|
Patil N, Crook J, Saibishkumar EP, Aneja
M, Borg J, Pond G and Ma C: The effect of obesity on rectal
dosimetry after permanent prostate brachytherapy. Brachytherapy.
8:218–222. 2009. View Article : Google Scholar
|
|
22
|
Susil RC, McNutt TR, DeWeese TL and Song
D: Effects of prostate-rectum separation on rectal dose from
external beam radiotherapy. Int J Radiat Oncol Biol Phys.
76:1251–1258. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Noyes WR, Hosford CC and Schultz SE: Human
collagen injections to reduce rectal dose during radiotherapy. Int
J Radiat Oncol Biol Phys. 82:1918–1922. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Stienstra R, Duval C, Müller M and Kersten
S: PPARs, obesity and inflammation. PPAR Res. 2007:959742007.
View Article : Google Scholar : PubMed/NCBI
|
